There was similar tumor incidence between heterozygous HSP70+/−neu+/− and WT-neu+/− mice (median tumor appearance in this strain was 66 weeks), indicating that one copy of the HSP70 genes is sufficient to support mammary tumorigenesis induced by HER2. Here, ERBB2 is linked to neoplasm.